Skip to main content

Table 1 Commercially available miRNA-based diagnostics

From: Can microRNA become next-generation tools in molecular diagnostics and therapeutics? A systematic review

Diagnostic marker

Number of miRNAs in panel

Disorder

Company

ThyraMIR/ThyGENX

10

Thyroid cancer

Interpace Diagnostics/Asuragen

OsteomiR

19

Osteoporosis

TAmiRNA

ThrombomiR

11

Cardiovascular diseases

TAmiRNA

miRview mets

64

Cancers of unknown primary origin (CUP)

Rosetta Genomics/Precision Therapeutics